会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 33. 发明公开
    • 루프로라이드의 제조방법
    • 制备紫杉醇的方法
    • KR1020110060779A
    • 2011-06-08
    • KR1020100023883
    • 2010-03-17
    • 애니젠 주식회사
    • 김재일전용국김대영윤영수김진권
    • C07K1/06C07K1/02C07K1/04
    • Y02P20/55C07K7/06C07K1/026C07K1/04C07K1/061
    • PURPOSE: A method for preparing leuprolide by solid phase synthesis and liquid phase reaction is provided to obtain a large amount of leuprolide peptide. CONSTITUTION: A method for preparing leuprolide comprises: a step of preparing a peptide of chemical formula I(pGlu-His(R1)-Trp(R2)-Ser(R3)-Tyr(R3)-D-Leu-Leu-Arg(R4)-O-resin) by solid phase synthesis; a step of removing the resin form the peptide to prepare a peptide of chemical formula II(pGlu-His(R1)-Trp(R2)-Ser(R3)-Tyr(R3)-D-Leu-Leu-Arg(R4)-OH); a step of coupling the peptide of chemical formula II with Pro-NH-R5 to prepare a peptide of chemical formula III(pGlu-His(R1)-Trp(R2)-Ser(R3)-Tyr(R3)-D-Leu-Leu-Arg(R4)-Pro-NH-R5); and a step of deprotecting the peptide of chemical formula III.
    • 目的:提供通过固相合成和液相反应制备亮丙瑞林的方法,以获得大量的亮丙瑞林肽。 构成:制备亮丙瑞林的方法包括:制备化学式I(pGlu-His(R1)-Trp(R2)-Ser(R3)-Tyr(R3)-D-Leu-Leu-Arg(pGlu- R4)-O-树脂); (pGlu-His(R1)-Trp(R2)-Ser(R3)-Tyr(R3)-D-Leu-Leu-Arg(R4))的肽,除去树脂形成肽以制备化学式II的肽的步骤 -哦); 将化学式II的肽与Pro-NH-R5偶合以制备化学式III的肽(pGlu-His(R1)-Trp(R2)-Ser(R3)-Tyr(R3)-D-Leu -Leu - 精氨酸(R 4)-Pro-NH-R 5); 和使化学式III的肽脱保护的步骤。
    • 34. 发明公开
    • 고체상 합성법을 이용한 옥트레오타이드의 제조방법
    • 一种通过固相合成制备异戊烯酸酯的方法
    • KR1020100021501A
    • 2010-02-24
    • KR1020100002115
    • 2010-01-11
    • 동국제약 주식회사
    • 차경회임대성이한원
    • C07K1/04C07K7/04C07K7/06C07K14/655
    • Y02P20/55C07K7/64C07K1/04C07K1/061
    • PURPOSE: A method for preparing octreotide having pharmacological activity is provided to release peptide on solid phase support and massively produce a target material with high yield and low cost. CONSTITUTION: A method for preparing octreotide comprises: a first step of reacting 3-methyl-3-butene-1-ol in bromo resin and reacting protected cystein with Fmoc group; a second step of reacting threoninol acetal in the resin to obtain amino acid-bound resin; a third step of synthesizing peptide to obtain peptide-resin connector of straight chain; a fourth step of adding DMF/anisole solution, Tl(tfa)3[thalium trifluoroacetate] mixsture liquid, iodine, Hg(mercury) bivalent ion or Ag(silver) monovalent ion sulfide grouop forming reagent to the connector; and a step of adding TFA[trifluoroacetic acid]: TIS[triisopropylsilane] mixture solution or DCM[dichloromethane] weak acid cleavage solution to the connector to remove side chain protection group.
    • 目的:提供一种制备具有药理活性的奥曲肽的方法,在固相支持下释放肽,并以高产率和低成本大量生产靶材。 构成:制备奥曲肽的方法包括:使3-甲基-3-丁烯-1-醇与溴树脂反应并使受保护的半胱氨酸与Fmoc基团反应的第一步; 在树脂中使苏糖醇缩醛反应得到氨基酸结合树脂的第二步骤; 合成肽以获得直链的肽 - 树脂连接体的第三步; 向连接器中加入DMF /苯甲醚溶液,Tl(tfa)3 [三氟乙酸三钠]混合液,碘,Hg(汞)二价离子或Ag(银)一价离子硫化物组合试剂的第四步骤; 以及将TFA [三氟乙酸]:TIS [三异丙基硅烷]混合物溶液或DCM [二氯甲烷]弱酸裂解溶液加入连接器以除去侧链保护基团的步骤。